iStreet Network Ltd. (ISTRNETWK): iStreet Network Share Price Rises 8.78% as Micro Cap Stock Gains Today

iStreet Network share price today stood at Rs 54.5, up 8.78%, taking market capitalisation to Rs 326.21 crore in a notable micro cap move.

iStreet Network Share Price moved to Rs 54.5 on 25 August 2026, up Rs 4.4 or 8.78% from the previous close of Rs 50.1, lifting the company’s market capitalisation to Rs 326.21 crore. That makes iStreet Network Share Price Today one of the more visible micro cap price rises in today’s market action, especially as the stock traded within a session range of Rs 51.5 to Rs 55.11 after opening at Rs 53.79.

For investors tracking iStreet Network Stock News and broader Stocks in News, the verified data confirms the price event clearly: the stock rose meaningfully in a single session, turnover reached Rs 0.74 crore and BSE volume stood at 1,36,643 shares. The supplied data confirms the price rise, but it does not establish a company-specific catalyst behind today’s move. That matters because price action can draw attention even when the trigger is not identified in the available dataset.

Why is it trending? First, iStreet Network Share Price Today recorded a gain large enough to place it in the day’s top gainer discussion for this dataset. Second, the company trades in the Healthcare sector and Pharmaceuticals & Drugs industry, where investors often compare valuation and profitability quickly when a small stock moves. Third, its valuation metrics are notable: a P/E ratio of 88.31 and P/B ratio of 7.37 stand well above the same-industry medians of 25.25 and 1.88 respectively.

For readers using Univest for iStreet Network Share News, the next things to monitor are whether price action holds near the day’s higher levels, how valuation compares with peers, and whether profitability metrics such as ROE and ROCE improve from their current 0 readings. This Univest analysis focuses on what the numbers say today, without stretching beyond the supplied facts.

iStreet Network Ltd. (ISTRNETWK) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 54.5
Previous Close	Rs 50.1
Today's Change	+Rs 4.4 (+8.78%)
Day Open	Rs 53.79
Day High	Rs 55.11
Day Low	Rs 51.5
Current Volume (BSE)	1,36,643
BSE Traded Volume	1,36,643
Combined NSE + BSE Volume	1,36,643
Turnover	Rs 0.74 crore
Market Capitalisation	Rs 326.21 crore
Market Cap Category	Micro Cap

iStreet Network Ltd. (ISTRNETWK) traded at Rs 54.5. versus the previous close of Rs 50.1, a rise of 8.78%. The stock opened at Rs 53.79, reached Rs 55.11, touched Rs 51.5. Reported volume was 1,36,643.

iStreet Network Ltd. (ISTRNETWK) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 326.21 crore
P/E Ratio	88.31x
P/B Ratio	7.37x
ROE	0%
ROCE	0%
EPS	Rs 0.57
Dividend Yield	0%

iStreet Network Ltd. was valued at a P/E ratio of 88.31x, a P/B ratio of 7.37x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 0% and ROCE of 0%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 0.57, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

iStreet Network Fundamental Analysis suggests that today’s price rise brings attention to valuation and profitability more than to scale. The company remains a micro cap business by market value, but its quoted multiples are much higher than broad industry medians, while return ratios are currently at zero.

At Rs 326.21 crore in market capitalisation, iStreet Network Market Cap is above the same-industry median market cap of Rs 141.75 crore but below the industry average of Rs 503.04 crore. That places the company in an interesting middle ground: larger than many smaller listed names in the Pharmaceuticals & Drugs benchmark set, but still well below the biggest listed peers in the supplied comparison pool.

The stock trades at a P/E ratio of 88.31. On its own, that tells investors the stock price is high relative to earnings per share, but the more useful comparison is with the sector benchmark. Within the same industry sample, the median P/E is 25.25 and the average is 40.09, while the range runs from 2.94 to 360.2 across 105 companies. Against that backdrop, iStreet Network’s P/E sits above both the median and average, which means the market is assigning a richer earnings multiple than the typical peer in the supplied universe.

The P/B ratio of 7.37 also stands above the benchmark median of 1.88 and the benchmark average of 2.6. Book-based valuation is therefore elevated versus much of the same-industry group. EPS is Rs 0.57, which indicates the earnings attributable to each share based on the supplied data. Dividend yield is 0, meaning the current historical payout contribution to the share price is nil in this snapshot.

Profitability metrics add important balance to the analysis. ROE is 0 and ROCE is 0, compared with industry medians of 10.21 and 12.98 and industry averages of 8.13 and 15.66 respectively. In practical terms, the stock’s current valuation is not being supported by positive return ratios in this dataset. For readers following iStreet Network Earnings, iStreet Network Financial Results and broader financial analysis on Univest, that is the key tension: the share price has risen sharply today, but the supplied fundamental profile remains expensive relative to sector medians while profitability measures are subdued. That naturally leads into the industry context and peer comparison.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	88.31x
Benchmark Median P/E	25.25x
Benchmark Average P/E	40.09x
Benchmark P/E Range	2.94x to 360.2x
Company P/B Ratio	7.37x
Benchmark Median P/B	1.88x
Company ROE	0%
Benchmark Median ROE	10.21%
Company ROCE	0%
Benchmark Median ROCE	12.98%
Company Market Capitalisation	Rs 326.21 crore
Benchmark Median Market Cap	Rs 141.75 crore

iStreet Network Ltd. (ISTRNETWK) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

iStreet Network Ltd. (ISTRNETWK) has a P/E ratio of 88.31x, which is above the benchmark median of 25.25x, a difference of +249.74%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

iStreet Network Ltd. (ISTRNETWK) has a ROE of 0%, which is below the benchmark median of 10.21%, a difference of -100%. iStreet Network Ltd. (ISTRNETWK) has a ROCE of 0%, which is below the benchmark median of 12.98%, a difference of -100%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

The Healthcare and Pharmaceuticals & Drugs backdrop shows why today’s move deserves a closer look. iStreet Network is being valued inside a 135-company same-industry benchmark set, and its key valuation multiples currently sit above central industry levels, while its return metrics sit below them.

The supplied sector snapshot places iStreet Network in Healthcare, specifically the Pharmaceuticals & Drugs industry. The benchmark scope is the same industry, covering 135 companies. That matters because it creates a like-for-like frame for comparing valuation, profitability and scale instead of using a broader market-wide average that could distort interpretation.

Start with earnings valuation. iStreet Network’s company P/E is 88.31. Within the same-industry benchmark, 105 companies had P/E data, with a median of 25.25, an average of 40.09, a minimum of 2.94 and a maximum of 360.2. This places iStreet Network above both the benchmark median and average, though still below the highest observed multiple in the sample. The stock is therefore not at the extreme top of the industry valuation range, but it is clearly richer than the central tendency.

On a price-to-book basis, the gap is similarly visible. Company P/B is 7.37, versus a benchmark median of 1.88 and average of 2.6 across 134 companies. The benchmark P/B range runs from -11.99 to 16.88. iStreet Network is well above the median and average on this measure too, showing that the market is pricing the stock at a premium to accounting net worth relative to many peers.

Returns tell a different story. Company ROE is 0 against a benchmark median of 10.21 and average of 8.13, while company ROCE is 0 versus a benchmark median of 12.98 and average of 15.66 across 134 companies. Scale-wise, the company’s market cap of Rs 326.21 crore compares with an industry median of Rs 141.75 crore, an average of Rs 503.04 crore, a minimum of Rs 5.81 crore and a maximum of Rs 2,970.3 crore. For Univest readers, the sector message is straightforward: the stock sits in a sizeable listed industry set where its valuation looks above benchmark norms, but its current return profile does not yet match that premium.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Solara Active Pharma Sciences Ltd.	SOLARA	2,970.3	0	2.38	17.23	15.34
Ind-Swift Laboratories Ltd.	INDSWFTLAB	2,864.08	49.64	1.9	-0.78	8.31
Dishman Carbogen Amcis Ltd.	DCAL	2,725.67	167.99	0.41	-2.89	-0.26
Hikal Ltd.	HIKAL	2,667	0	2.2	15.22	16.15
Beta Drugs Ltd.	BETA	2,588.69	61.85	9.78	18.65	22.17

iStreet Network Ltd. (ISTRNETWK) has a P/E ratio of 88.31x compared with the displayed peer median of 49.64x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 0% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. iStreet Network Ltd. (ISTRNETWK) has a market capitalisation of Rs 326.21 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Peer comparison sharpens the picture around iStreet Network Share Price by showing where the stock stands relative to other listed Pharmaceuticals & Drugs companies on market cap, valuation and return ratios. The supplied peer set is skewed toward much larger companies, which makes the valuation differences especially noticeable.

At Rs 326.21 crore, iStreet Network is much smaller than every named peer in the supplied list. Solara Active Pharma Sciences carries a market cap of Rs 2,970.3 crore, Ind-Swift Laboratories stands at Rs 2,864.08 crore, Dishman Carbogen Amcis at Rs 2,725.67 crore, Hikal at Rs 2,667 crore and Beta Drugs at Rs 2,588.69 crore. Even the lower end of the peer examples shown remains far above iStreet Network in size.

On valuation, iStreet Network’s P/E ratio of 88.31 is higher than Ind-Swift Laboratories at 49.64, Beta Drugs at 61.85, Fredun Pharmaceuticals at 53.93 and Venus Remedies at 19.59. It is below Dishman Carbogen Amcis at 167.99, Sai Parenteral's at 141.7 and Indoco Remedies at 360.2. That places the stock in the upper half of the supplied peer valuation band, rather than at the most expensive edge.

The P/B ratio of 7.37 is above Solara’s 2.38, Ind-Swift’s 1.9, Dishman’s 0.41, Hikal’s 2.2, Panacea Biotec’s 2.98, Sai Parenteral's 3, Venus Remedies’ 3.31 and Indoco Remedies’ 2.02. It is below Beta Drugs at 9.78 and Fredun Pharmaceuticals at 8.06. So on book-value valuation, iStreet Network also screens as relatively expensive versus most peers listed here.

Profitability is where the contrast becomes sharper. iStreet Network’s ROE and ROCE are both 0. That is below Solara’s 17.23 ROE and 15.34 ROCE, Hikal’s 15.22 and 16.15, Beta Drugs’ 18.65 and 22.17, Fredun’s 11.42 and 13.15, Venus Remedies’ 9.85 and 7.89, and Indoco’s 12.85 and 15.67. Panacea Biotec also has ROE at 0, but its ROCE is 5.36. Dishman Carbogen Amcis and Ind-Swift Laboratories show negative or weak return metrics on some lines, reminding investors that the industry itself includes a broad spread of operating outcomes. For Univest users tracking iStreet Network Stock Performance, the peer takeaway is that valuation is elevated relative to many peers, while return ratios remain comparatively soft.

Why Investors Are Watching iStreet Network

Investors are watching iStreet Network because today’s move combines strong one-day price action with a valuation profile that stands out against both sector benchmarks and listed peers. In stock market today screens, that mix often pushes a small-cap or micro cap name into active monitoring even when the available dataset does not confirm a specific corporate trigger.

• Verified price action: iStreet Network Share Price rose 8.78% to Rs 54.5 from Rs 50.1, after opening at Rs 53.79 and touching Rs 55.11.
• Intraday range: The stock traded between Rs 51.5 and Rs 55.11, showing meaningful price action within the session.
• Trading activity: BSE volume, current volume and total volume were all 1,36,643 shares, with turnover at Rs 0.74 crore.
• Fundamental context: P/E of 88.31 and P/B of 7.37 are above the same-industry medians of 25.25 and 1.88.
• Profitability context: ROE and ROCE are both 0, below industry medians of 10.21 and 12.98.
• Sector positioning: The company operates in Healthcare, within Pharmaceuticals & Drugs, a benchmark universe of 135 companies.

What should investors monitor next? The key markers are whether iStreet Network Share Price holds above the previous close after today’s rise, whether valuation remains far above industry medians, and whether future company financials begin to support stronger return ratios. Univest readers should focus on the combination of price behaviour, market capitalisation context and comparative valuation rather than assuming that a single session move alone changes the long-term financial picture.

About iStreet Network

iStreet Network Ltd. is classified in the Healthcare sector and the Pharmaceuticals & Drugs industry in the supplied dataset. That industry label is important because it sets the framework for how the market is currently comparing the stock, including P/E ratio, P/B ratio, ROE, ROCE and market capitalisation against other listed pharmaceutical and drug-related businesses.

Based on the verified data available here, the company is being assessed by the market alongside a same-industry benchmark universe of 135 companies. That means investors looking at iStreet Network Share Price, iStreet Network Company News and iStreet Network Latest News are likely to judge it less against broad market averages and more against sector-specific listed names such as Solara Active Pharma Sciences, Ind-Swift Laboratories, Dishman Carbogen Amcis, Hikal and Beta Drugs.

In market-position terms, iStreet Network’s market cap of Rs 326.21 crore is above the industry median of Rs 141.75 crore but below the industry average of Rs 503.04 crore. So while it is firmly a micro cap stock, it is not among the smallest names in the same-industry benchmark. The current pricing of the stock also suggests that the market is assigning a premium earnings and book-value multiple relative to many peers. For readers using Univest to follow iStreet Network NSE, iStreet Network BSE and iStreet Network Shareholding Pattern pages, the most factual company overview available in this dataset is its sector placement, industry grouping and relative standing within the listed Pharmaceuticals & Drugs universe.

Track iStreet Network Share Price on Univest

Use iStreet Network Ltd. (ISTRNETWK) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors who want a structured view of iStreet Network Share Price can track the stock on Univest through a combination of live share price data, market cap updates and comparative ratio analysis. That includes following day moves, 52-week positioning where available, valuation multiples such as P/E and P/B, and broader stock analysis across sector and peer groups.

Univest also helps readers keep iStreet Network Stock News in one place by combining price action, market movers data, company financial metrics and industry context. For users monitoring iStreet Network Share Price Today, the most useful approach is to watch whether fresh price action is supported by changes in valuation, profitability and relative position within the Healthcare and Pharmaceuticals & Drugs benchmark set. That keeps the focus on verified numbers instead of market noise.

Frequently Asked Questions

Why is iStreet Network Share Price rising today?

Ans. iStreet Network Share Price rose because the stock gained 8.78% in the session, moving to Rs 54.5 from the previous close of Rs 50.1. The supplied data confirms the price event, though it does not identify a company-specific catalyst.

What is iStreet Network Share Price Today?

Ans. iStreet Network Share Price Today was Rs 54.5 at the event time. That represented a gain of Rs 4.4 or 8.78% over the previous close of Rs 50.1, making it a notable micro cap mover in today’s trade.

What were the day high, day low and opening price for iStreet Network?

Ans. The stock opened at Rs 53.79, touched a day high of Rs 55.11 and a day low of Rs 51.5. This intraday band shows active price movement around today’s rise rather than a narrow, low-volatility session.

How much volume was traded in iStreet Network today?

Ans. iStreet Network recorded current volume of 1,36,643 shares on BSE, with total volume also at 1,36,643 shares. Turnover was Rs 0.74 crore, showing the move was accompanied by measurable trading activity in the cash market.

What is the market capitalisation of iStreet Network?

Ans. The company’s market capitalisation stood at Rs 326.21 crore in the supplied data. That places iStreet Network in the Micro Cap category and above the same-industry median market cap of Rs 141.75 crore.

Is iStreet Network expensive compared with its industry on P/E?

Ans. On the supplied numbers, iStreet Network looks expensive versus its industry median on earnings valuation. Its P/E ratio is 88.31, compared with the same-industry median of 25.25 and average of 40.09 across 105 companies.

How does iStreet Network compare with its industry on P/B?

Ans. iStreet Network’s P/B ratio is 7.37, which is above the same-industry median of 1.88 and average of 2.6. That means the stock is trading at a higher price-to-book multiple than many pharmaceutical peers in the benchmark.

What do the ROE and ROCE numbers show for iStreet Network?

Ans. The supplied profitability metrics show ROE at 0 and ROCE at 0. Both are below the same-industry medians of 10.21 and 12.98, indicating the current return profile is weaker than the benchmark’s central levels.

Which sector and industry does iStreet Network belong to?

Ans. iStreet Network is classified under the Healthcare sector and Pharmaceuticals & Drugs industry in the supplied dataset. Its valuation and profitability are therefore best read against the same-industry benchmark universe of 135 listed companies.

What should investors watch next in iStreet Network Stock News?

Ans. Investors can watch whether iStreet Network holds above the previous close after today’s 8.78% rise, and whether future financial performance improves on ROE, ROCE and valuation support. Peer comparisons and sector benchmark gaps also remain important.